CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
31 hedge funds and large institutions have $1.87M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
96% less capital invested
Capital invested by funds: $49.2M → $1.87M (-$47.3M)
Holders
31
Holding in Top 10
1
Calls
$15K
Puts
$12K
Top Buyers
| 1 | +$478K | |
| 2 | +$326K | |
| 3 | +$194K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$170K |
| 5 |
Morgan Stanley
New York
|
+$93.7K |
Top Sellers
| 1 | -$9.75M | |
| 2 | -$6.77M | |
| 3 | -$5.31M | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$4.11M |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$3.32M |